Registry Strategy Boosts Diverse Parkinsonism Trial Enrollment
A new registry-based approach improves research participation rates for diverse patients at a New York City facility.
Updated on Oct. 27, 2026 in Alzheimer’s

Live Poll
Should medical researchers implement targeted strategies to ensure diversity in clinical trial participation?
Researchers at the James J Peters Veterans Affairs Medical Center implemented a registry-based strategy to improve diverse enrollment in parkinsonism clinical trials. Published on September 11, 2026, the study found the initiative achieved equitable research participation rates among Black, Hispanic, and White patients.
Why it matters
The approach was designed to reduce selection bias in clinical research, ensuring that trial cohorts better reflect the racial and ethnic diversity of the broader patient population. By addressing barriers to entry, the model aims to improve the quality and applicability of neurological study findings.
The study cohort included 192 patients with a median age of 76, of which 96.4% were men. Findings showed 29.7% of the cohort suffered from severe parkinsonism, while researchers successfully invited 87.0% of all eligible patients to join the CANPARK study.
The players
James J Peters Veterans Affairs Medical Center
This facility is a major health provider in New York City that serves veterans and supports various clinical research initiatives.
American Parkinson Disease Association
This national organization provides support, education, and funding for research dedicated to improving the lives of those affected by Parkinson disease.
Department of Veterans Affairs
This federal agency operates the national healthcare system for veterans and provides significant funding for medical research programs.
The details
Investigators used a real-time Standard of Care Registry to track demographic and clinical data for patients at the James J Peters Veterans Affairs Medical Center. To boost participation, the team employed flexible protocols, bilingual staff, transportation support, and coordinated research procedures with existing clinical appointments.
Timeline
The study data collection period began in December 2022.
The study data collection period concluded in June 2024.
Study findings were published on September 11, 2026.
The Big Picture
This effort follows the protocol established by the CANPARK study to address long-standing gaps in clinical trial representation. The findings demonstrate a scalable model for improving diversity in neurological research.
The implementation of coordinated, inclusive research protocols can reduce barriers to accessing advanced clinical treatments for patients with parkinsonism. By integrating study procedures with routine clinic visits, patients may find it easier to participate in medical trials without extra travel or scheduling burdens.
The takeaway
Proactive efforts to remove logistical barriers are essential for achieving representative clinical research outcomes. Researchers can significantly boost participation by aligning study requirements with the practical needs and schedules of their patient populations.
Further reading
Learn more about local clinical research efforts on the New York City Alzheimer’s section.
Source note: This article includes information reported by Neurology Advisor.
Live Poll
Should medical researchers implement targeted strategies to ensure diversity in clinical trial participation?










